文献速递甲状腺与浅表US

人工智能优化ACR TI-RADS与原始ACR TI-RADS诊断准确性和效用的比较:基于2061个甲状腺结节的多中心验证研究

Comparison of diagnostic accuracy and utility of artificial intelligence-optimized ACR TI-RADS and original ACR TI-RADS: a multi-center validation study based on 2061 thyroid nodules.
PubMed 文献 · Eur Radiol · 2022-05-04

该研究回顾性分析2017年1月至2020年7月间经细针穿刺或手术取样的2061个甲状腺结节(1859例患者),由两名放射科医师分别用ACR TI-RADS和AI TI-RADS评分。AI TI-RADS较ACR TI-RADS风险分级更低(p<0.001),AUC更大(0.762 vs 0.679,p<0.001),敏感度相似(86.7% vs 82.2%,p=0.052),特异度更高(70.2% vs 49.2%,p<0.001),并可减少不必要的细针穿刺。

要点

  • AI TI-RADS较ACR TI-RADS风险分级更低(p<0.001),AUC更大(0.762 vs 0.679,p<0.001)。
  • 两者敏感度相似(86.7% vs 82.2%,p=0.052),AI TI-RADS特异度更高(70.2% vs 49.2%,p<0.001)。
  • AI TI-RADS将743个(48.63%)良性结节降级,可避免328个(占776个活检结节的42.3%)不必要的细针穿刺。

核心结论

  • AI TI-RADS可实质性减少推荐活检的良性甲状腺结节数量,并显著提高特异度,尽管敏感度略有下降。

研究设计与样本

  • 多中心回顾性分析,纳入2017年1月至2020年7月间经细针穿刺或手术取样的2061个甲状腺结节(1859例患者),由两名对病理诊断不知情的放射科医师按五个超声类别评估结节特征并分别用ACR TI-RADS和AI TI-RADS评分;另两名放射科医师独立对100个结节评分以评估评分者间一致性;参考标准为术后病理或根据Bethesda系统的细胞病理诊断;评分者间一致性用组内相关系数(ICC)确定。

诊断标准与关键数值

  • AI TI-RADS较ACR TI-RADS分配更低的TI-RADS风险级别(p<0.001);AI TI-RADS的AUC为0.762,ACR TI-RADS为0.679(p<0.001);ACR TI-RADS敏感度86.7% vs AI TI-RADS 82.2%(p=0.052),AI TI-RADS特异度70.2% vs ACR TI-RADS 49.2%(p<0.001);AI TI-RADS将743个(48.63%)良性结节降级,提示可避免328个(占776个活检结节的42.3%)不必要的细针穿刺;评分者间一致性AI TI-RADS的ICC为0.808,ACR TI-RADS为0.861(p<0.001)。

临床应用与阅片要点

  • AI TI-RADS可在保持与ACR TI-RADS相似敏感度的同时提高特异度,减少良性甲状腺结节的不必要细针穿刺,并可改善评分者间一致性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine if artificial intelligence-based modification of the Thyroid Imaging Reporting Data System (TI-RADS) would be better than the current American College of Radiology (ACR) TI-RADS for risk stratification of thyroid nodules.

METHODS: A total of 2061 thyroid nodules (in 1859 patients) sampled with fine-needle aspiration or operation were retrospectively analyzed between January 2017 and July 2020. Two radiologists blinded to the pathologic diagnosis evaluated nodule features in five ultrasound categories and assigned TI-RADS scores by both ACR TI-RADS and AI TI-RADS. Inter-rater agreement was assessed by asking another two radiologists to score a set of 100 nodules independently. The reference standard was postoperative pathological or cytopathological diagnosis according to the Bethesda system. Inter-rater agreement was determined using intraclass correlation coefficient (ICC).

RESULTS: AI TI-RADS assigned lower TI-RADS risk levels than ACR TI-RADS (p < 0.001) and had larger area under receiver operating characteristic curve (0.762 vs. 0.679, p < 0.001). The sensitivities of ACR TI-RADS and AI TI-RADS were similar (86.7% vs. 82.2%, p = 0.052), but specificity was higher with AI TI-RADS (70.2% vs. 49.2%, p < 0.001). AI TI-RADS downgraded 743 (48.63%) benign nodules, indicating that 328 (42.3% of 776 biopsied nodules) unnecessary fine-needle aspirations (FNA) could have been avoided. Inter-rater agreement was better with AI TI-RADS than with ACR TI-RADS (ICC, 0.808 vs. 0.861, p < 0.001).

CONCLUSION: AI TI-RADS can achieve meaningful reduction in the number of benign thyroid nodules recommended for biopsy and significantly improve specificity despite a slight decrease in sensitivity.

KEY POINTS: • AI TI-RADS assigned lower TI-RADS risk levels than ACR TI-RADS, showing similar sensitivity but higher specificity. • Half of the benign nodules can be downgraded of which 42.3% of biopsy nodules avoided unnecessary fine-needle aspiration (FNA). • AI TI-RADS had a better overall inter-rater agreement.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu, Li, Yan, et al. Comparison of diagnostic accuracy and utility of artificial intelligence-optimized ACR TI-RADS and original ACR TI-RADS: a multi-center validation study based on 2061 thyroid nodules. Eur Radiol. 2022. PMID: 35505119. doi:10.1007/s00330-022-08827-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。